Angiotensin inhibitors during neoadjuvant chemotherapy improve esophageal squamous cell carcinoma outcomes
Therapeutic Advances in Medical Oncology
Published online on May 23, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
Background:The renin–angiotensin–aldosterone system (RAAS) is implicated in the initiation, progression, and therapeutic response of several solid malignancies. RAAS inhibitors (angiotensin system inhibitors) exhibit potential antitumor effects; however, ...
Background:The renin–angiotensin–aldosterone system (RAAS) is implicated in the initiation, progression, and therapeutic response of several solid malignancies. RAAS inhibitors (angiotensin system inhibitors) exhibit potential antitumor effects; however, ...